TOT BIOPHARM International Co Ltd
HKEX:1875
TOT BIOPHARM International Co Ltd
Revenue
TOT BIOPHARM International Co Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
T
|
TOT BIOPHARM International Co Ltd
HKEX:1875
|
Revenue
¥780.6m
|
CAGR 3-Years
226%
|
CAGR 5-Years
82%
|
CAGR 10-Years
N/A
|
Beigene Ltd
HKEX:6160
|
Revenue
¥17.4B
|
CAGR 3-Years
102%
|
CAGR 5-Years
68%
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Revenue
¥6.2B
|
CAGR 3-Years
17%
|
CAGR 5-Years
266%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Revenue
¥5.5B
|
CAGR 3-Years
33%
|
CAGR 5-Years
41%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Revenue
¥53.1B
|
CAGR 3-Years
48%
|
CAGR 5-Years
51%
|
CAGR 10-Years
53%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Revenue
¥1.9B
|
CAGR 3-Years
51%
|
CAGR 5-Years
54%
|
CAGR 10-Years
N/A
|
See Also
What is TOT BIOPHARM International Co Ltd's Revenue?
Revenue
780.6m
CNY
Based on the financial report for Dec 31, 2023, TOT BIOPHARM International Co Ltd's Revenue amounts to 780.6m CNY.
What is TOT BIOPHARM International Co Ltd's Revenue growth rate?
Revenue CAGR 5Y
82%
Over the last year, the Revenue growth was 77%. The average annual Revenue growth rates for TOT BIOPHARM International Co Ltd have been 226% over the past three years , 82% over the past five years .